Largest Drug Companies

Market cap a/o Q1 2016 (in billions USD)

Johnson & Johnson, $298.9B
Roche, $208.8B
Novartis, $195.2B
Pfizer, $186.4B
Merck & Co., $148B
Gilead Sciences, $124.9B
Amgen, $113.3B
Novo Nordisk, $112B
Sanofi, $106.6B
Bristol-Myers Squibb, $105.4B
GlaxoSmithKline, $100.2B
Bayer, $97.1B
AbbVie, $92.5B
Eli Lilly & Co, $79.7B
Celgene, $77.6B
AstraZeneca, $70.9B
Abbott Laboratories, $62B
Biogen, $56.6B
Teva Pharmaceutical, $54.1B
Stryker Corporation, $40.2B
Regeneron Pharmaceuticals Inc, $37.3B
Shire Pharmaceuticals, $34B
Alexion Pharmaceuticals, $31.6B
Baxalta Inc, $27.5B
Mylan, $22.8B